Relmada Therapeutics Stock Forward View - Relative Strength Index
| RLMD Stock | USD 3.80 0.03 0.78% |
Relmada Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Relmada Therapeutics stock prices and determine the direction of Relmada Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Relmada Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, The relative strength index (RSI) of Relmada Therapeutics' share price is at 50 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Relmada Therapeutics, making its price go up or down. Momentum 50
Impartial
Oversold | Overbought |
EPS Estimate Current Year (0.83) | EPS Estimate Next Year (0.36) | Wall Street Target Price 5.5 |
Using Relmada Therapeutics hype-based prediction, you can estimate the value of Relmada Therapeutics from the perspective of Relmada Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Relmada Therapeutics using Relmada Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Relmada using crowd psychology based on the activity and movement of Relmada Therapeutics' stock price.
Relmada Therapeutics Short Interest
A significant increase or decrease in Relmada Therapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Relmada. Short interest can provide insight into the potential direction of Relmada Therapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 1.0887 | Short Percent 0.013 | Short Ratio 0.62 | Shares Short Prior Month 1.4 M | 50 Day MA 2.6086 |
Relmada Relative Strength Index
Relmada Therapeutics Hype to Price Pattern
Investor biases related to Relmada Therapeutics' public news can be used to forecast risks associated with an investment in Relmada. The trend in average sentiment can be used to explain how an investor holding Relmada can time the market purely based on public headlines and social activities around Relmada Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Relmada Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Relmada Therapeutics.
Relmada Therapeutics Implied Volatility | 1.83 |
Relmada Therapeutics' implied volatility exposes the market's sentiment of Relmada Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Relmada Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Relmada Therapeutics stock will not fluctuate a lot when Relmada Therapeutics' options are near their expiration.
Relmada Therapeutics after-hype prediction price | USD 3.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. Open Interest Against 2026-03-20 Relmada Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Relmada Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Relmada Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Relmada Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Relmada Therapeutics' open interest, investors have to compare it to Relmada Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Relmada Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Relmada. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Relmada Therapeutics Additional Predictive Modules
Most predictive techniques to examine Relmada price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Relmada using various technical indicators. When you analyze Relmada charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 50.78 | 50.78 |
| Check Relmada Therapeutics Volatility | Backtest Relmada Therapeutics | Information Ratio |
Relmada Therapeutics Trading Date Momentum
| On February 03 2026 Relmada Therapeutics was traded for 3.80 at the closing time. The top price for the day was 3.83 and the lowest listed price was 3.55 . There was no trading activity during the period 0.0. Lack of trading volume on February 3, 2026 did not cause price change. The trading delta at closing time against the current closing price is 0.79% . |
| Compare Relmada Therapeutics to competition |
Other Forecasting Options for Relmada Therapeutics
For every potential investor in Relmada, whether a beginner or expert, Relmada Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Relmada Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Relmada. Basic forecasting techniques help filter out the noise by identifying Relmada Therapeutics' price trends.Relmada Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Relmada Therapeutics stock to make a market-neutral strategy. Peer analysis of Relmada Therapeutics could also be used in its relative valuation, which is a method of valuing Relmada Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Relmada Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Relmada Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Relmada Therapeutics shares will generate the highest return on investment. By undertsting and applying Relmada Therapeutics stock market strength indicators, traders can identify Relmada Therapeutics entry and exit signals to maximize returns.
Relmada Therapeutics Risk Indicators
The analysis of Relmada Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Relmada Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting relmada stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.45 | |||
| Semi Deviation | 4.11 | |||
| Standard Deviation | 6.17 | |||
| Variance | 38.13 | |||
| Downside Variance | 21.04 | |||
| Semi Variance | 16.86 | |||
| Expected Short fall | (5.72) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Relmada Therapeutics
The number of cover stories for Relmada Therapeutics depends on current market conditions and Relmada Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Relmada Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Relmada Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Relmada Therapeutics Short Properties
Relmada Therapeutics' future price predictability will typically decrease when Relmada Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Relmada Therapeutics often depends not only on the future outlook of the potential Relmada Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Relmada Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 30.2 M | |
| Cash And Short Term Investments | 44.9 M |
Check out Historical Fundamental Analysis of Relmada Therapeutics to cross-verify your projections. For information on how to trade Relmada Stock refer to our How to Trade Relmada Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Will Pharmaceuticals sector continue expanding? Could Relmada diversify its offerings? Factors like these will boost the valuation of Relmada Therapeutics. Anticipated expansion of Relmada directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Relmada Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Relmada Therapeutics's market price often diverges from its book value, the accounting figure shown on Relmada's balance sheet. Smart investors calculate Relmada Therapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Relmada Therapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Relmada Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Relmada Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Relmada Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.